Skip to content

Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking

Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking

Status
Enrolling by invitation
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07625956
Acronym
Pack2Pouch+
Enrollment
10
Registered
2026-06-04
Start date
2026-06-26
Completion date
2026-10-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking ( Cigarette)

Brief summary

Some people who smoke cigarettes try to switch to oral nicotine pouches but are not able to fully stop smoking. This study tests two new strategies for people who previously tried to switch using nicotine pouches. Participants who were unable to fully switch will either be asked to increase the nicotine strength of their pouches or to use a nicotine patch along with pouches. The goal of the study is to see whether these strategies are feasible, acceptable, and helpful, and to inform the design of larger future studies.

Interventions

DRUGNicotine replacement therapy patches

Nicotine replacement therapy patches will be dosed based on current cigarette smoking at the end of the parent trial.

Zyn oral nicotine pouches will be provided in the flavor preference of the participant and dosed based on their randomization in the parent trial and randomization in the extension study.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 21 years or older * Currently enrolled in and completed the Pack2Pouch parent study * Current combustible tobacco smoking at extension study enrollment * Able to attend in-person visits in the Charleston, SC area * Access to internet and mobile communication

Exclusion criteria

* Pregnancy, breastfeeding, or nursing * Medical contraindications to nicotine replacement therapy * Current use of smoking cessation medications * Non-English proficiency * Use of other combustible tobacco or frequent non-combustible nicotine products outside study protocol

Design outcomes

Primary

MeasureTime frameDescription
FeasibilityDays 1-56Feasibility endpoints include 1) the proportion of eligible subjects who subsequently enroll; 2) the proportion of enrolled subjects who complete the Day 28 and Day 56 assessments; and 3) the proportion of enrolled subjects who complete ≥80% of their daily surveys during the switching period.
AcceptabilityDay 28Acceptability endpoints will be measured by the Acceptability of Intervention Measure (AIM). This measure includes 4 items rated on scale of 1 to 5. Scores are created by averaging responses, with values ranging from 1 to 5. Higher values indicate higher acceptability.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAmanda Palmer, PhD

Medical University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026